Appraising Medical Trial Experiences of Ovarian Cancer Patients

NCT05801796NOT_YET_RECRUITINGOBSERVATIONAL

Summary

Key Facts

Lead Sponsor

Power Life Sciences Inc.

Enrollment

500

Start Date

2024-04-01

Completion Date

2025-04-01

Study Type

OBSERVATIONAL

Official Title

Analyzing Factors of Patient Involvement in Ovarian Cancer Clinical Trials

Conditions

Ovarian Cancer

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

* Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
* Patient has been diagnosed with ovarian cancer
* Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion Criteria:

* Inability to perform regular electronic reporting
* Patient does not understand, sign, and return consent form
* Pregnant, breastfeeding or expecting to conceive within the projected duration of the study

Outcome Measures

Primary Outcomes

Patient decides to enroll in clinical trial

Time frame: 3 Months

Patient remains in clinical trial to completion

Time frame: 12 months

Appraising Medical Trial Experiences of Ovarian Cancer Patients